Written by Aisha Saleem, Pharmacist & Health Writer at PharmaHealths.com
Last Updated: July 2026
Anxiety disorders are the most common mental health conditions worldwide. The World Health Organization estimates that around 301 million people globally live with an anxiety disorder and many either remain untreated or receive treatment that does not fully match their symptoms.
Medication is one of the most effective tools available for anxiety, but the options are more varied than most people realize during a routine consultation. Understanding which medications are used, how they work, when they are appropriate, and what the real risks look like can help you make more confident and informed decisions about your care.
This guide covers everything a pharmacist would want you to know before starting anxiety medication or deciding whether medication is the right step for you.
Why Do Doctors Prescribe Antidepressants for Anxiety?
SSRIs and SNRIs are the most commonly prescribed medications for anxiety disorders, and if you have been prescribed one, you may have wondered why an antidepressant is being used to treat anxiety.
The answer is that the name is misleading. SSRIs and SNRIs do not simply treat depression. They modulate the serotonin and noradrenaline systems that underlie both mood and anxiety regulation. The same neurobiological pathways involved in depression are dysregulated in anxiety disorders, which is why the same class of medications is first line for both conditions. This is not a repurposing or a workaround. It is the appropriate pharmacological approach, supported by the strongest evidence base of any medication class for anxiety disorders.
A systematic review and meta-analysis published in The Lancet found that SSRIs and SNRIs were significantly more effective than placebo for generalized anxiety disorder, panic disorder, and social anxiety disorder, with a robust and consistent evidence base across all three conditions. NICE, the American Psychiatric Association, and the World Health Organization all recommend SSRIs or SNRIs as first line pharmacological treatment for anxiety disorders.
Common SSRIs used for anxiety include sertraline, escitalopram, fluoxetine, paroxetine, and fluvoxamine. Among SNRIs, venlafaxine and duloxetine have the most evidence for anxiety.
The most important practical point about SSRIs and SNRIs for anxiety is that they take time. Most patients do not experience meaningful anxiety reduction for two to six weeks after starting, and full therapeutic benefit can take eight to twelve weeks. In the first one to two weeks, some patients experience a temporary increase in anxiety, which can feel discouraging but is a known and usually short-lived effect. Starting at the lowest available dose and increasing gradually can make this phase much easier to tolerate.
What Medication Is Used for Each Type of Anxiety Disorder?
Anxiety is not one condition. It is a family of distinct disorders with overlapping but different clinical profiles, and medication choice is not identical across them.
Generalized anxiety disorder is treated first line with SSRIs or SNRIs, with buspirone as a recommended alternative, and pregabalin increasingly used in patients who have not responded adequately to first line options. NICE guideline CG113 specifically recommends sertraline as the first-choice SSRI for GAD.
Panic disorder responds well to SSRIs and SNRIs, which reduce both attack frequency and severity over time. Among SSRIs, sertraline, fluoxetine, and escitalopram have the strongest evidence. Tricyclic antidepressants are also effective but are rarely used first line due to their side effect profile.
Social anxiety disorder has the strongest evidence base for SSRIs, particularly paroxetine, sertraline, and escitalopram, and for the SNRI venlafaxine. Beta blockers are sometimes used for performance specific anxiety situations but are not effective for the broader disorder.
Specific phobias are generally not treated with long term medication. Exposure based psychological therapy is the primary treatment, with short term anxiolytic use occasionally considered for unavoidable exposure situations only.
What Is Buspirone and When Is It Used?
Buspirone is a non-benzodiazepine anxiolytic that is specifically indicated for generalized anxiety disorder. It works as a partial agonist at serotonin 5 HT1A receptors, a different mechanism from both SSRIs and benzodiazepines, and produces anxiolytic effects without sedation, cognitive impairment, or dependence risk.
Buspirone’s key advantage over benzodiazepines is its complete absence of dependency potential. It does not produce tolerance, withdrawal, or rebound anxiety on discontinuation, which makes it a clinically attractive option for patients requiring longer term treatment.
Its key limitation is the same as SSRIs. It takes three to four weeks to reach full effect, making it unsuitable for acute or as needed use.
Research consistently supports buspirone’s efficacy for GAD, though effect sizes are generally modest compared to SSRIs. It is best positioned as a first line alternative for patients who cannot tolerate SSRIs or as an add on when partial response is the clinical picture.
What Is Pregabalin and Why Is It Increasingly Used for Anxiety?
Pregabalin is an anticonvulsant medication that has become an important option for anxiety, particularly GAD. It works by binding to voltage gated calcium channels in the central nervous system, reducing excessive neuronal excitability and helping calm physical symptoms such as muscle tension and restlessness.
A meta-analysis confirmed that pregabalin was significantly more effective than placebo for GAD, with a faster onset of action than SSRIs. NICE includes pregabalin as an option when first line treatments have not been effective.
Pregabalin carries some risk of dependence, lower than benzodiazepines but still present. Its regulatory status varies by country, and in some regions, it is classified as a controlled medication due to misuse concerns. Sedation and dizziness are the most common side effects and are typically dose dependent.
What Are Benzodiazepines and Why Are They Used Short Term Only?
Benzodiazepines such as diazepam, lorazepam, clonazepam, and alprazolam work by enhancing the activity of GABA, the brain’s primary inhibitory neurotransmitter. They produce rapid and powerful calming effects, typically within 30 to 60 minutes.
The reason benzodiazepines are recommended for short term use only is the risk of tolerance and dependence. With repeated use, the brain adapts by reducing its own GABA receptor sensitivity, requiring higher doses for the same effect and producing withdrawal symptoms on discontinuation.
This is not a weakness in the patient. It is a predictable pharmacological response.
Benzodiazepines are appropriate in specific situations such as acute anxiety episodes, short term bridging while waiting for SSRIs to work, or unavoidable high stress events. They are not suitable for long term daily use.
If you have been using a benzodiazepine for more than four weeks, tapering under medical supervision is essential rather than stopping suddenly.
What Are Beta Blockers and When Do They Help Anxiety?
Beta blockers, particularly propranolol, do not treat anxiety at its psychological root. Instead, they reduce physical symptoms such as rapid heart rate, shaking, and sweating by blocking adrenaline effects.
This makes them useful for performance anxiety, such as public speaking or exams, where physical symptoms are the main concern.
For general anxiety disorders, their role is limited and usually supportive rather than primary treatment.
What Is Hydroxyzine and Is It Worth Considering?
Hydroxyzine is an antihistamine with calming effects on the central nervous system. It works quickly and does not cause dependence, tolerance, or withdrawal.
This makes it a useful option for short term or situational anxiety, especially in patients where benzodiazepines are not appropriate.
The main limitation is sedation, along with dry mouth and blurred vision, which can affect daily functioning.
How to Talk to Your Doctor About Anxiety Medication
One of the most important steps in anxiety treatment is having a clear and productive conversation with your doctor.
• Be specific about your symptoms. Describe how anxiety feels, how often it occurs, and how it affects your daily life.
• Be clear about what you have already tried, including therapy, lifestyle changes, or previous medications.
• Ask about available options, including medication and therapy. Combining both often gives better outcomes than either alone.
• If you are worried about side effects or dependence, say so openly. This helps your doctor choose a treatment that aligns better with your comfort and long-term goals.
Conclusion
Anxiety medication is not a single solution. It includes a range of options such as SSRIs, SNRIs, buspirone, pregabalin, beta blockers, hydroxyzine, and benzodiazepines, each with a different role.
The most important point is that SSRIs and SNRIs are first line treatments for most anxiety disorders. Benzodiazepines may feel effective quickly but are not suitable for long term use due to dependence risk.
The second key point is that medication works best when combined with therapy. Addressing both the biological and behavioral aspects of anxiety leads to more lasting improvement.
Anxiety is treatable. The options are effective, and with the right approach, most people can achieve meaningful and sustained relief.
Disclaimer
This article is for general informational and educational purposes only and does not constitute medical advice, a diagnosis, or a treatment recommendation. Anxiety disorders require proper clinical assessment and management by a qualified healthcare professional. Never start, stop, or change any medication without medical supervision. Benzodiazepine withdrawal in particular carries serious risks and must always be managed with medical guidance.
References
• Cipriani A et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. The Lancet. 2018. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(17)32802-7/fulltext
• National Institute for Health and Care Excellence. Generalized Anxiety Disorder and Panic Disorder in Adults: Management. NICE Guideline CG113. https://www.nice.org.uk/guidance/cg113
• World Health Organization. Mental Health Action Plan 2013-2030. https://www.who.int/publications/i/item/9789240031029
• International Journal of Neuropsychopharmacology. Pregabalin for generalized anxiety disorder: meta-analysis. https://academic.oup.com/ijnp
• Garakani A et al. Pharmacotherapy of anxiety disorders: current and emerging treatment options. Frontiers in Psychiatry. 2020. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786299
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders Fifth Edition Text Revision DSM-5-TR. 2022. https://www.psychiatry.org/psychiatrists/practice/dsm • BMJ. Prescribing benzodiazepines in young adults with anxiety: qualitative study of GP perspectives. https://bjgp.org
